关注
Juan Antonio Marchal
Juan Antonio Marchal
在 ugr.es 的电子邮件经过验证
标题
引用次数
年份
047 Changes in proteome of membrane fractions from bovine oocyte to zygote
J Romero-Aguirregomezcorta, J Peña, P Graván, JG Hamzé, JA Marchal, ...
Animal-science proceedings 14 (3), 459-460, 2023
2023
1-(Benzenesulfonyl)-1, 5-dihydro-4, 1-benzoxazepine as a new scaffold for the design of antitumor compounds
O Cruz-López, A Ramírez, SA Navarro, MA García, JA Marchal, ...
Future Medicinal Chemistry 9 (11), 1129-1140, 2017
32017
5-fluorouracil derivatives induce differentiation mediated by tubulin and HLA class I modulation
JA Marchal, H Boulaiz, F Rodriguez-Serrano, M Peran, E Carrillo, C Velez, ...
Medicinal Chemistry 3 (3), 233-239, 2007
132007
5-Fluorouracil derivatives: a patent review
P Álvarez, JA Marchal, H Boulaiz, E Carrillo, C Vélez, ...
Expert opinion on therapeutic patents 22 (2), 107-123, 2012
1262012
5-Fluorouracil derivatives: a patent review (2012–2014)
E Carrillo, SA Navarro, A Ramírez, MÁ García, C Griñán-Lisón, M Perán, ...
Expert opinion on therapeutic patents 25 (10), 1131-1144, 2015
532015
5200 A new combined therapy strategy to breast cancer treatment: assay of E gene transfection associated to citotoxic drugs in multicellular tumour spheroid
AR Rama, C Melquizo, J Prados, R Ortiz, F Rodriguez-Serrano, H Boulaiz, ...
EJC Supplements 2 (7), 319-320, 2009
2009
6′-Chloro-7-or 9-(2, 3-dihydro-5H-4, 1-benzoxathiepin-3-yl)-7H-or 9H-purines and their corresponding sulfones as a new family of cytotoxic drugs
MC Núñez, F Rodríguez-Serrano, JA Marchal, O Caba, A Aránega, ...
Tetrahedron 63 (1), 183-190, 2007
292007
95 Transfection of the gene e and later application of cytotoxic drugs in the treatment of breast multicellular tumour solid cancer
ARR Ballesteros, J Prados, C Melquizo, R Ortiz, F Rodriguez-Serrano, ...
EJC Supplements 3 (8), 86, 2010
2010
A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer
M Perán, E López-Ruiz, MÁ García, S Nadaraia-Hoke, R Brandt, ...
Scientific Reports 7 (1), 13998, 2017
162017
A morphometric study of the human fetal heart with perimembranous ventricular septal defects
L Alvarez, A Aranega, R Saucedo, JA Marchal, AR González, ...
Cardiology in the Young 5 (1), 63-69, 1995
1995
A novel biomimetic knee joint bioreactor for the in vitro regeneration of osteochondral lesions
N Campillo, A Torres, C Romo, S Micó, C Chocarro-Wrona, J López, ...
TISSUE ENGINEERING PART A 28, 358-358, 2022
12022
A scalable method for the production of exosomes derived from CAR-T cells
P Heredia, K Pavlovic, B Perucha, M Cortijo, V Ronco, F Martin, ...
HUMAN GENE THERAPY 33 (23-24), A134-A134, 2022
2022
A soft 3D polyacrylate hydrogel recapitulates the cartilage niche and allows growth-factor free tissue engineering of human articular cartilage
G Jiménez, S Venkateswaran, E López-Ruiz, M Perán, S Pernagallo, ...
Acta Biomaterialia 90, 146-156, 2019
292019
A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells
JA Marchal, MC Núñez, I Suárez, M Díaz-Gavilán, JA Gómez-Vidal, ...
Breast cancer research and treatment 105, 237-246, 2007
302007
A versatile theranostic nanodevice based on an orthogonal bioconjugation strategy for efficient targeted treatment and monitoring of triple negative breast cancer
MV Cano-Cortes, SA Navarro-Marchal, MP Ruiz-Blas, JJ Diaz-Mochon, ...
Nanomedicine: Nanotechnology, Biology and Medicine 24, 102120, 2020
272020
A worldwide overview of regulatory frameworks for tissue-based products
CV Oberweis, JA Marchal, E López-Ruiz, P Gálvez-Martín
Tissue Engineering Part B: Reviews 26 (2), 181-196, 2020
412020
Abstract P6-05-01: Interactions between adipocytes and breast cancer cells stimulate cytokine production and drive Src/SOX2/miR-302b mediated malignant progression
M Picon-Ruiz, C Pan, K Drewes-Elger, K Jang, A Besser, D Zaho, ...
Cancer Research 78 (4_Supplement), P6-05-01-P6-05-01, 2018
2018
Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells
JA Marchal, J Prados, C Melguizo, JE Fernández, C Velez, L Alvarez, ...
Journal of Laboratory and Clinical Medicine 130 (1), 42-50, 1997
261997
Activating transcription factor 4 modulates TGFβ-induced aggressiveness in triple-negative breast cancer via SMAD2/3/4 and mTORC2 signaling
A González-González, E Muñoz-Muela, JA Marchal, FE Cara, MP Molina, ...
Clinical Cancer Research 24 (22), 5697-5709, 2018
542018
Actividad selectiva de nuevos fármacos con potencial terapeútico frente a cáncer de mama
JA Marchal, I Suárez, H Boulaiz, E Carrillo, A Martínez-Amat, FR Serrano, ...
Actualidad médica 92 (773), 31-38, 2006
2006
系统目前无法执行此操作,请稍后再试。
文章 1–20